secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2022-05-24T23:59:59+00:00
Accession:  0001193125-22-158523
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Eliem Therapeutics shareholders elect three directors, ratify PwC as auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Robert Azelby, Judith Dunn, Adam Rosenberg elected Class I directors with >20M votes for each.
- PricewaterhouseCoopers LLP ratified as independent auditor for FY2022 with 24,137,141 votes for, 4,086 against.
- Broker non-votes: 1,346,296 on director elections; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312522158523/0001193125-22-158523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312522158523/d535085d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-158523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer